Immunic has raised €17.5 million from LSP and LifeCare Partners in Series A round and bought cytokine inhibitor and Crohn’s disease programs from 4SC.

National Institutes of Health (NIH) researchers say DNA methylation is persistently altered in individuals with a smoking history, and the results may lead to…

Shire has returned rights to the two biosimilars that Baxalta had in development.

Galapagos CEO Onno van de Stolpe has confirmed that the standstill agreement stopping Gilead from increasing its stake in his company is still active.

Boston Scientific has agreed to acquire EndoChoice for approximately $210 million in a deal that will see the latter folding into Boston Sci’s endoscopy…

EarlySense, which markets a contactless vital sign monitoring system for hospitals, is expanding into post-acute care with a system designed specifically for…

BMS has partnered with Nektar Therapeutics in a clinical collaboration that aims to boost the efficacy of Opdivo with Nektar candidate NKTR-214.

Startup Fortis has emerged from stealth mode with an $18 million Series A financing led by Avalon Ventures.

Amgen’s Kyprolis has come up short against Takeda’s Velcade in a Phase III trial in patients newly diagnosed with multiple myeloma.